Medi-Vet

Medivet Biologics, now operating as Ardent Animal Health, is a biotechnology company specializing in regenerative medicine and personalized biologics for the veterinary market. The company provides point-of-care solutions that enable veterinarians to treat companion animals using their own biological materials, including adipose-derived stem cell therapy and platelet-rich plasma (PRP). Their flagship product, the Canine Autologous Cancer Vaccine (K9-ACV), is designed to stimulate the immune system to target specific tumor antigens following surgical removal. Medivet Biologics focuses on translating advanced human medical research into accessible clinical treatments for chronic conditions such as osteoarthritis and various pet cancers. The company maintains a strong presence in the animal health sector through proprietary processing technologies and academic collaborations.